Meanwhile, the business is also planning to license its skin-imaging technology and software to hospitals and health authorities.
“We have already started the funding roadshow. We are aiming to launch the series A round in the second quarter of 2023. We have a good investment base already and we think a number of them will come again,” said Mr O’Reilly, who cofounded the business about four years ago with dermatologist Rupert Barry.
Other backers include corporate lawyers Paddy Sweetman and Stanley Watson, former MCD communications chief Justin Green, Niall Fortune’s Eddie Rockets chain, as well as a slew of medical consultants from top hospitals. Mr O’Reilly said DermView is planning to use its imaging technology to expand beyond dermatology into other areas. Next month, it will launch a pilot project with the Mater hospital in Dublin for ophthalmology services, to help diagnose eye conditions.